"St. Joseph Hospital is a values-based Catholic health care provider with a tradition of and commitment to excellence, based on the vision of the Sisters of St. Joseph of Orange. The hospital's strong belief in the intrinsic dignity of each person commits it to be a just employer to its 3,800 employees; to provide health care for the whole person - body, mind and spirit; and to collaborate with the 1,000-member medical staff and other health care providers to increase access to quality health care."

During the past decade, Saint Joseph Hospital - Orange conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 63 clinical trials were completed, i.e. on average, 84% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 34 clinical trials were completed. i.e. 178.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Hospital - Orange" #1 sponsor was "National Cancer Institute (NCI)" with 46 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "Gynecologic Oncology Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Hospital - Orange" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Hospital - Orange" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (7 trials), "Glioblastoma" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Saint Joseph Hospital - Orange" in a lesser frequency.

Most popular intervention types in "Saint Joseph Hospital - Orange" are "Drug" (100 trials), "Other" (74 trials), "Biological" (48 trials), "Procedure" (31 trials) and "Device" (27 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (31 trials), "Paclitaxel" (19 trials), "Questionnaire Administration" (16 trials) and "Carboplatin" (15 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Hospital - Orange" are 130 trials for "All" genders, 30 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Hospital - Orange". undefined are not yet recruiting, 26 are recruiting, 58 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Saint Joseph Hospital - Orange, 3 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Hospital - Orange, 4 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 25 trials that are defined as “Not Applicable".

Saint Joseph Hospital - Orange has several departments that took part in Clinical trials: "St. Joseph Hospital Regional Cancer Center - Orange" - 36 trials, "St. Joseph Hospital of Orange Heart and Vascular Center" - 3 trials